Loading
Life sciences · Journal article
World Journal of Advanced Research and Reviews · September 13, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Macrophagic activation syndrome is a rare, severe and often fatal immunological complication associated with a wide range of conditions such as: infections, cancers and auto immune diseases. We report a case of a young patient of 22 years old, admitted for acute pancreatitis in a febrile context and poor general condition. Later we confirmed the diagnosis of multifocal tuberculosis (pulmonary, ganglionic and peritoneal) complicated by Macrophagic Activation Syndrome. The diagnosis has been established upon clinical, biological and radiological criteria with a microbiological confirmation of tuberculosis. The treatment administered consisted of adapted antitubercular antibiotics and high-dose corticosteroid therapy, which lead to a favorable clinical evolution. This case report illustrates the importance of considering a Macrophagic Activation Syndrome in front of unexplained biological anomalies in a tuberculosis patient, even with no known history of immunodepression.